PLK1 and primary cutaneous T-cell non-Hodgkin lymphoma: It was reported that the down-regulation of PLK1 induced apoptosis [61], premature senescence [62], and elevation drug sensitivity [63] of breast cancer cells and decreased the viability of cancer cells in endothelial cells [64], cell cycle arrest, and apoptosis of cutaneous T-cell lymphomas [65].